يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Lung Diseases drug therapy"', وقت الاستعلام: 1.46s تنقيح النتائج
  1. 1

    المساهمون: Service des Maladies infectieuses et tropicales [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de Référence Listeria - National Reference Center Listeria (CNRL), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre collaborateur de l'OMS Listeria / WHO Collaborating Centre Listeria (CC-OMS / WHO-CC), Institut Pasteur [Paris]-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Biologie des Infections - Biology of Infection, Université Paris Descartes - Paris 5 (UPD5), Funding was received from the Institut Pasteur, Santé Publique, France., Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), DIAKITE, andrée

    المصدر: Clinical Microbiology and Infection
    Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, 24 (12), pp.1339.e1-1339.e5. ⟨10.1016/j.cmi.2018.03.003⟩
    Clinical Microbiology and Infection, 2018, 24 (12), pp.1339.e1-1339.e5. ⟨10.1016/j.cmi.2018.03.003⟩

    مصطلحات موضوعية: Lung Diseases, Male, 0301 basic medicine, MESH: Respiratory Tract Infections/epidemiology, MESH: Listeria monocytogenes/isolation & purification, MESH: Empyema, Pleural/microbiology, Pleural effusion, MESH: Empyema, Pleural/etiology, medicine.medical_treatment, [SDV]Life Sciences [q-bio], MESH: Empyema, Pleural/drug therapy, MESH: Listeriosis/epidemiology, MESH: Listeriosis/drug therapy, MESH: Aged, 80 and over, listeriosis, pleural effusion, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Sepsis/etiology, MESH: Anti-Bacterial Agents/therapeutic use, Respiratory Tract Infections, MESH: Respiratory Tract Infections/etiology, Aged, 80 and over, MESH: Aged, Pleuropneumonia, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Middle Aged, Respiratory infection, Immunosuppression, General Medicine, Middle Aged, MESH: Pneumonia, Bacterial/drug therapy, MESH: Pneumonia, Bacterial/etiology, MESH: Sepsis/epidemiology, Anti-Bacterial Agents, 3. Good health, [SDV] Life Sciences [q-bio], Infectious Diseases, medicine.anatomical_structure, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, MESH: Lung Diseases/microbiology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Pneumonia, Bacterial/microbiology, Female, MESH: Empyema, Pleural/epidemiology, medicine.drug, Adult, Microbiology (medical), MESH: Pleuropneumonia/microbiology, MESH: Pneumonia, Bacterial/epidemiology, MESH: Lung Diseases/epidemiology, medicine.medical_specialty, 030106 microbiology, MESH: Pleuropneumonia/drug therapy, 03 medical and health sciences, MESH: Listeriosis/complications, Sepsis, Internal medicine, Pneumonia, Bacterial, medicine, Humans, pneumonia, MESH: Sepsis/drug therapy, MESH: Lung Diseases/drug therapy, [SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology, MESH: Respiratory Tract Infections/drug therapy, Empyema, Pleural, Aged, Retrospective Studies, MESH: Pleuropneumonia/etiology, MESH: Sepsis/microbiology, Lung, MESH: Humans, business.industry, MESH: Respiratory Tract Infections/microbiology, MESH: Adult, MESH: Retrospective Studies, Amoxicillin, medicine.disease, Listeria monocytogenes, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Empyema, MESH: Male, Pneumonia, MESH: Lung Diseases/etiology, Concomitant, MESH: Listeriosis/microbiology, MESH: Listeria monocytogenes/drug effects, MESH: Pleuropneumonia/epidemiology, [SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, business, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

    وصف الملف: application/pdf

  2. 2

    المصدر: Ostgård, L S G, Nørgaard, J M, Sengeløv, H, Severinsen, M, Smidstrup Friis, L, Werenberg Marcher, C, Høgh Dufva, I & Nørgaard, M 2015, ' Comorbidity and performance status in acute myeloid leukemia patients : a nation-wide population-based cohort study ', Leukemia, vol. 29, no. 3, pp. 548-555 . https://doi.org/10.1038/leu.2014.234
    Østgård, L S G, Nørgaard, J M, Sengeløv, H, Severinsen, M, Friis, L S, Marcher, C W, Dufva, I H & Nørgaard, M 2015, ' Comorbidity and performance status in acute myeloid leukemia patients : a nation-wide population-based cohort study ', Leukemia, pp. 548-55 . https://doi.org/10.1038/leu.2014.234
    Ostgård, L S G, Nørgaard, J M, Sengeløv, H, Severinsen, M, Friis, L S, Marcher, C W, Dufva, I H & Nørgaard, M 2015, ' Comorbidity and performance status in acute myeloid leukemia patients : a nation-wide population-based cohort study ', Leukemia, vol. 29, no. 3, pp. 548–555 . https://doi.org/10.1038/leu.2014.234

  3. 3

    المصدر: American Journal of Medical Genetics. Part A, vol. 149A, no. 9, pp. 2045-2049
    American Journal of Medical Genetics. A, Vol. 149A, No 9 (2009) pp. 2045-2049

    وصف الملف: application/pdf

  4. 4